Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Federal funding cuts are disrupting pediatric brain cancer research in 2026, delaying progress on treatments for a rare childhood disease.
Federal funding cuts that began in late 2025 continue to disrupt pediatric brain cancer research in 2026, according to Dr. Rachael Sirianni of UMass Chan Medical School.
Reduced support has delayed experiments, hindered staffing and equipment maintenance, and undermined long-term planning.
The uncertainty is threatening progress in developing treatments for a rare and deadly childhood disease, highlighting broader challenges in sustaining federal investment in rare disease research.
4 Articles
Los recortes de fondos federales están interrumpiendo la investigación de cáncer cerebral pediátrico en 2026, retrasando el progreso en los tratamientos para una enfermedad infantil rara.